Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of AST-001 in children with autism spectrum disorder
KCT0007519Phase 2Completed
- Sponsor
- Astrogen
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Threonine in Autism Spectrum Disorder (ASD), sponsored by Astrogen. Started Feb 2021; status: completed.
02
Drugs
Threonine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on KCT0007519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007519.